Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-6 of 6 (Search time: 0.001 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2017Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancerPonnusamy, S.; Coss, C.; Thiyagarajan, T.; Watts, K.; Hwang, D.-J.; He, Y.; Selth, L.; McEwan, I.; Duke, C.; Pagadala, J.; Singh, G.; Wake, R.; Ledbetter, C.; Tilley, W.; Moldoveanu, T.; Dalton, J.; Miller, D.; Narayanan, R.
2015Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapiesChan, S.; Selth, L.; Li, Y.; Nyquist, M.; Miao, L.; Bradner, J.; Raj, G.; Tilley, W.; Dehm, S.
2007Identification of novel androgen receptor target genes in prostate cancerJariwala, U.; Prescott, J.; Jia, L.; Barski, A.; Pregizer, S.; Cogan, J.; Arasheben, A.; Tilley, W.; Scher, H.; Gerald, W.; Buchanan, G.; Coetzee, G.; Frenkel, B.
2011GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cellsChiam, K.; Centenera, M.; Butler, L.; Tilley, W.; Bianco-Miotto, T.; Agoulnik, I.
2012An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activityMoore, N.; Buchanan, G.; Harris, J.; Selth, L.; Bianco-Miotto, T.; Hanson, A.; Birrell, S.; Butler, L.; Hickey, T.; Tilley, W.
2014PRMT2 and RORĪ³ expression are associated with breast cancer survival outcomesOh, T.; Bailey, P.; Dray, E.; Smith, A.; Goode, J.; Eriksson, N.; Funder, J.; Fuller, P.; Simpson, E.; Tilley, W.; Leedman, P.; Clarke, C.; Grimmond, S.; Dowhan, D.; Muscat, G.